Jubilant Pharmova posts robust Q3, eyes Vision 2030 with sterile injectables drive
The board highlighted ongoing investments in Radiopharma, CDMO Sterile Injectables, and CRDMO businesses
The board highlighted ongoing investments in Radiopharma, CDMO Sterile Injectables, and CRDMO businesses
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The SNS records neural activity from 60 channels across four brain regions—far exceeding current commercial devices
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
From material selection to cooling tower management, every small decision affects long-term equipment reliability
The FDA’s review also revealed delays in Philips’ internal investigations, with 54 inquiries failing to meet targeted completion dates—23 of which were delayed by more than 100 days
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
The company reported a 28% year-on-year increase in Q2 revenue to Rs. 220.9 crore
The Q1 2025 also witnessed a successful launch of Allegra D
Subscribe To Our Newsletter & Stay Updated